JOYANG LABORATORIES

Overview

JOYANG LABORATORIES is an active pharmaceutical ingredient (API) supplier with 9 active FDA Type II Drug Master Files, covering ADENOSINE; BACITRACIN; BACITRACIN ZINC; CYCLOSPORINE (NON-STERILE BULK FORM); FUSIDIC ACID; MYCOPHENOLATE MOFETIL.

Core services & business areas

Active pharmaceutical ingredients supplied

Substances JOYANG LABORATORIES is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

JOYANG LABORATORIES holds 9 active (12 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• PIOGLITAZONE HYDROCHLORIDEActive2025-11-27
• MYCOPHENOLATE MOFETILActive2025-10-30
• MYCOPHENOLATE SODIUMActive2024-12-19
• ADENOSINEActive2024-10-25
• SODIUM FUSIDATEActive2021-10-08
• BACITRACINActive2015-04-07
• FUSIDIC ACIDActive2015-01-31
• BACITRACIN ZINCActive2013-11-25
• CYCLOSPORINE (NON-STERILE BULK FORM)Active2005-09-06
• TacrolimusInactive2020-03-03
• BACITRACIN USPInactive2011-10-10
• BACITRACIN ZINCInactive2011-06-24

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to JOYANG LABORATORIES in our records. PharmaTek screens the full directory against live FDA enforcement data.